Unity Biotechnology, Inc. (UBX) Covered Calls

You can sell covered calls on Unity Biotechnology, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for UBX (prices last updated Fri 4:16 PM ET):

Unity Biotechnology, Inc. (UBX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.61 -0.02 1.60 1.63 31K - 0.0
Covered Calls For Unity Biotechnology, Inc. (UBX)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 2 0.00 1.63 0.0% 0.0%
Jun 21 2 0.00 1.63 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 that is in Phase II clinical trial for musculoskeletal/ osteoarthritis disease, as well as Phase Ib clinical trial for moderate-to-severe osteoarthritis of the knee; UBX1325, which is Phase I clinical trial for the treatment of diabetic macular edema; and UBX1967 for the treatment of ophthalmologic diseases. It is also developing programs in pulmonary disorders and neurological disorders, as well as kidney and liver diseases. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is headquartered in South San Francisco, California.